Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues
Briefly

Omada Health's metabolic health program has become the entry point for most new employers, focusing on GLP-1 care track, as it increasingly dominates customer inquiries.
Duffy stated that although weight loss wasn't the primary focus, it has taken precedence in their employer pitches due to the emphasis on metabolic care.
The startup initially expected employers to use Omada as a gatekeeper for GLP-1 drug coverage, but most have opted for more liberal coverage choices.
As Omada approaches its IPO, the recent surge in interest in their weight loss program has been a surprising but welcomed change in employer expectations.
Read at Business Insider
[
|
]